Video | Agriculture | Confidence | Economy | Energy | Employment | Finance | Media | Property | RBNZ | Science | SOEs | Tax | Technology | Telecoms | Tourism | Transport | Search

 


While you were sleeping: Pfizer, Eli Lilly lift mood

While you were sleeping: Pfizer, Eli Lilly lift mood

Jan 30 (BusinessDesk) – Better-than-expected profit outlooks from drug makers Pfizer and Eli Lilly bolstered Wall Street, while a rise in US home prices also underpinned optimism that the economic recovery is kicking into gear.

Shares of Pfizer gained, last up 3.1 percent, after the company predicted 2013 profit that surpassed expectations. So did Eli Lilly, boosting its shares 3.8 percent.

Of the 174 companies in the S&P 500 that have reported earnings this season, 68.4 percent have been above analyst expectations, according to Thomson Reuters data.

There was bright news on US house prices, which posted their biggest annual gain since 2006. The S&P/Case Shiller composite index of 20 metropolitan areas increased 0.6 percent in November on a seasonally adjusted basis, and jumped 5.5 percent year over year, the most since August 2006.

"What we're seeing is really a gradual improvement in the overall economy," Anthony Chan, chief economist for Chase Private Client in New York, told Reuters.

In afternoon trading in New York, the Dow Jones Industrial Average rose 0.52 percent, while the Standard & Poor's 500 Index gained 0.12 percent. The Nasdaq Composite Index slipped 0.10 percent. Earlier the Dow rose as high as 13,954.04, the highest level in five years.

And that optimism also helped fuel a gain in oil prices to the highest level in four months.

"We’re pricing in a lot of economic optimism,” Mike Wittner, head of oil-market research for the Americas at Societe Generale in New York, told Bloomberg News. “The underlying macroeconomic picture looks solid and that’s good for demand.”

Even so, consumer confidence slumped in January, declining to the lowest level since November 2011, with the Conference Board’s index sliding to 58.6 this month, from a revised 66.7 in December.

It wasn't all good news on the earnings front either. Shares of VMware plunged, last down 20.9 percent, after the software maker predicted first-quarter revenue that fell short of expectations.

Seagate also missed the mark in its revenue outlook, sending its shares 9.5 percent lower.

US Federal Reserve policy makers began a two-day meeting today.

“The Fed meeting will be as always very closely watched,” Hank Smith, who helps oversee US$6.5 billion as chief investment officer of Haverford Trust told Bloomberg. “The market’s going to be very curious and read into any commentary as to if the Fed lets on as to when this non-traditional easing will start to end.”

In Europe, the Stoxx 600 Index ended the day with a 0.3 percent advance from the previous close. It's at the highest level in nearly two years. Stocks in London, Frankfurt, and Paris also gained, rising 0.7 percent, 0.2 percent and 0.1 percent respectively.

(BusinessDesk)

© Scoop Media

 
 
 
 
 
Business Headlines | Sci-Tech Headlines

 

What Winter? Temperature Records Set For June 20-22

The days around the winter soltice produced a number of notably warm tempertaures. More>>

Conservation Deal: New Kākāpō Recovery Partnership Welcomed

Conservation Minister Maggie Barry says the new kakapo recovery partnership between DOC and Meridian Energy is great news for efforts to save one of New Zealand’s most beloved birds. More>>

ALSO:

Tech Sector Report: Joyce Warns Asian Tech Investors View NZ As Hobbits And Food

Speaking in Wellington at the launch of a report showcasing the value of the technology sector to the New Zealand economy, Joyce said more had to be done to tell the country's technology stories overseas. More>>

ALSO:

Mediaglommeration: APN Gets OIO Approval For Demerger Plan

APN News & Media has received Overseas Investment Office approval for its plan to split out its NZME unit ahead of a potential merger with rival Fairfax Media's New Zealand operations. More>>

New Paper: Ninety-Day Trial Period Has No Impact On Firms' Hiring

The introduction of a 90-day trial period has had no impact on hiring by New Zealand companies although they are now in widespread use, according to researchers at Motu Economic and Public Policy Research. More>>

ALSO:

Corrections: Serco Exits Equity Stake, Remains As Operator

Serco has sold its equity stake in the company that holds the contract to design, build and run Wiri Prison in South Auckland but continues as sub-contractor to operate the facility. More>>

GDP: NZ Economy Grows Faster-Than-Forecast 0.7%

New Zealand's economy grew at a faster pace than expected in the first quarter of 2016 as construction expanded at the quickest rate in two years. The kiwi dollar jumped after the data was released. More>>

ALSO:

Get More From Scoop

 
 
 
 
 
 
 
 
 
Business
Search Scoop  
 
 
Powered by Vodafone
NZ independent news